PYPAXO Trademark

Trademark Overview


On Wednesday, August 30, 2017, a trademark application was filed for PYPAXO with the United States Patent and Trademark Office. The USPTO has given the PYPAXO trademark a serial number of 79221472. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, May 20, 2021. This trademark is owned by NOVARTIS AG. The PYPAXO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pre...
pypaxo

General Information


Serial Number79221472
Word MarkPYPAXO
Filing DateWednesday, August 30, 2017
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, May 20, 2021
Registration Number5435741
Registration DateTuesday, April 3, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2018

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, May 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, April 3, 2022NOTIFICATION PROCESSED BY IB
Saturday, September 4, 2021NOTIFICATION PROCESSED BY IB
Sunday, June 6, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, June 6, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, May 25, 2018NOTIFICATION PROCESSED BY IB
Monday, May 7, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 7, 2018FINAL DISPOSITION PROCESSED
Thursday, May 3, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Saturday, January 27, 2018NOTIFICATION PROCESSED BY IB
Tuesday, January 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 10, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 10, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 27, 2017NOTICE OF PUBLICATION
Saturday, December 9, 2017APPLICATION FILING RECEIPT MAILED
Friday, December 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 5, 2017ASSIGNED TO EXAMINER
Tuesday, December 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 24, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 23, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB